ParaZero (PRZO) highlights DropAir blood transfusion breakthrough with IDF in 6-K

Rhea-AI Filing Summary

ParaZero Technologies Ltd. filed a Form 6-K to furnish a press release dated September 9, 2025. The press release is titled “ParaZero’s DropAir Achieves Life-Saving Breakthrough in Precision Critical Blood Transfusions Delivery with IDF and Israeli Ministry of Defense,” highlighting work involving DropAir, the IDF, and Israel’s Ministry of Defense.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of September 2025

Commission file number: 001-41760

ParaZero Technologies Ltd.

(Translation of registrant’s name into English)

1 Hatachana Street

Kfar Saba, 4453001, Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

CONTENTS

Attached hereto and incorporated herein is the Registrant’s press release issued on September 9, 2025, titled “ParaZero’s DropAir Achieves Life-Saving Breakthrough in Precision Critical Blood Transfusions Delivery with IDF and Israeli Ministry of Defense.”

1

EXHIBIT INDEX

Exhibit No.
99.1		Press release titled: “ParaZero’s DropAir Achieves Life-Saving Breakthrough in Precision Critical Blood Transfusions Delivery with IDF and Israeli Ministry of Defense”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ParaZero Technologies Ltd.
Date: September 9, 2025	By:	/s/ Ariel Alon
		Name:	Ariel Alon
		Title:	Chief Executive Officer

3

FAQ

What did ParaZero Technologies Ltd. (PRZO) report in its September 2025 Form 6-K?

ParaZero Technologies Ltd. submitted a Form 6-K to provide investors with a press release dated September 9, 2025. The release reports a life-saving breakthrough by its DropAir system in precision delivery of critical blood transfusions with the IDF and Israel’s Ministry of Defense.

What is the focus of ParaZero’s press release titled about DropAir for PRZO investors?

The press release focuses on ParaZero’s DropAir achieving a life-saving breakthrough in precision delivery of critical blood transfusions. It specifically mentions collaboration with the Israel Defense Forces and the Israeli Ministry of Defense in achieving this operational capability.

How is ParaZero’s DropAir described in the PRZO Form 6-K filing?

DropAir is described through the press release title as achieving a life-saving breakthrough in precision critical blood transfusions delivery. The title emphasizes accurate delivery of critical blood supplies in partnership with the IDF and Israel’s Ministry of Defense.

Which partners are mentioned in ParaZero’s DropAir blood transfusion breakthrough?

The press release title notes that ParaZero’s DropAir breakthrough in precision critical blood transfusions delivery was achieved with the IDF and the Israeli Ministry of Defense. These two partners are the only collaborators referenced in the filing excerpt.

Does the ParaZero (PRZO) Form 6-K include financial or earnings information?

The Form 6-K excerpt only indicates that ParaZero furnished a press release about DropAir’s life-saving blood transfusion delivery breakthrough. It does not present earnings, revenue figures, or financial performance data in the provided content.

Why did ParaZero file this Form 6-K regarding the DropAir blood transfusion breakthrough?

ParaZero filed the Form 6-K to officially furnish its September 9, 2025 press release. This allows the company to place the disclosed DropAir breakthrough in precision critical blood transfusions delivery with the IDF and Israel’s Ministry of Defense into the public regulatory record.